Psychedelic Stock Gainers And Losers From January 24, 2023
Psychedelic Stock Gainers And Losers From January 24, 2023
自 2023 年 1 月 24 日起 Psychedelic 股票的涨跌幅
GAINERS:
赢家:
- Biomind Labs (OTC:BMNDF) shares closed up 67.76% at $0.61
- GH Research (NASDAQ:GHRS) shares closed up 4.62% at $9.73
- Numinus Wellness (OTC:NUMIF) shares closed up 1.62% at $0.21
- ATAI Life Sciences (NASDAQ:ATAI) shares closed up 1.06% at $1.91
- 生物心理实验室 (场外交易代码:BMNDF)股价收盘上涨67.76%,至0.61美元
- 生长激素研究 纳斯达克股票代码:GHRS)股价收盘上涨4.62%,至9.73美元
- 努米努斯健康 (场外交易代码:NUMIF)股价收盘上涨1.62%,至0.21美元
- ATAI 生命科学 纳斯达克股票代码:ATAI)股价收盘上涨1.06%,至1.91美元
LOSERS:
失败者:
- Cybin (AMEX:CYBN) shares closed down 2.99% at $0.40
- Mind Medicine (NASDAQ:MNMD) shares closed down 2.95% at $3.45
- Seelos Therapeutics (NASDAQ:SEEL) shares closed down 0.19% at $0.92
- Compass Pathways (NASDAQ:CMPS) shares closed down 0.67% at $10.47
- Intelgenx Technologies (OTC:IGXT) shares closed down 0.88% at $0.23
- Cybin (AMEX: CYBN)股价收盘下跌2.99%,至0.40美元
- 心灵医学 纳斯达克股票代码:MNMD)股价收盘下跌2.95%,至3.45美元
- Seelos Therap 纳斯达克股票代码:SEEL)股价收盘下跌0.19%,至0.92美元
- 罗盘之路 纳斯达克股票代码:CMPS)股价收盘下跌0.67%,至10.47美元
- 英特尔根克斯科技 (场外交易代码:IGXT)股价收盘下跌0.88%,至0.23美元
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。